Key Laboratory of Gene Engineering, Ministry of Education, State Key Laboratory of Biocontrol, Collaborative Innovation Center for Cancer Medicine, School of Life Sciences, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; and.
Department of Laboratory Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
FASEB J. 2018 Jul;32(7):3936-3945. doi: 10.1096/fj.201701199R. Epub 2018 Feb 20.
Resistance to TGF-β-induced growth repression is prevalent in various cancer cells, but the underlying mechanisms remain unclear. In this study, we showed that activation of TGF-β signaling caused Sma- and Mad-related family (Smad) 2 and Smad3 to bind directly to the promoter region of miR-195, and then activated miR-195 transcription in normal hepatocytes. Conversely, miR-195 inhibited the expression of Smad7 by binding to its 3'-UTR, thereby strengthening TGF-β-Smad signaling. These data identify a novel TGF-β-miR-195 positive regulatory circuitry in normal hepatocytes. Further investigation revealed that HDAC1, a histone deacetylase that was abnormally overexpressed in hepatocellular carcinoma, could bind to the miR-195 promoter via Smad3 and cause hypoacetylation in the histones associated with the miR-195 promoter in hepatoma cells. This resulted in transcriptional repression of miR-195 and, subsequently, disruption of the TGF-β-miR-195 regulatory loop and evasion of TGF-β-mediated growth inhibition. Moreover, silencing HDAC1 in hepatoma cells restored TGF-β-mediated growth suppression, but this effect was attenuated if miR-195 expression decreased. These findings suggest that HDAC1-induced miR-195 down-regulation is an important mechanism for tumor cells to resist the cytostatic activity of TGF-β, and highlight the importance of TGF-β-Smad2/3-miR-195-Smad7 circuitry in preventing uncontrolled cell proliferation.-Wang, R., Fu, T., You, K., Li, S., Zhao, N., Yang, J., Zhuang, S.-M. Identification of a TGF-β-miR-195 positive feedback loop in hepatocytes and its deregulation in hepatoma cells.
在各种癌细胞中普遍存在对 TGF-β 诱导的生长抑制的抗性,但潜在机制尚不清楚。在这项研究中,我们表明 TGF-β 信号的激活导致 Smad 家族(Smad)2 和 Smad3 直接与 miR-195 的启动子区域结合,然后在正常肝细胞中激活 miR-195 转录。相反,miR-195 通过结合其 3'-UTR 抑制 Smad7 的表达,从而增强 TGF-β-Smad 信号。这些数据确定了正常肝细胞中新型 TGF-β-miR-195 正调控回路。进一步的研究表明,组蛋白去乙酰化酶 1(HDAC1)是肝癌中异常过表达的组蛋白去乙酰化酶,可通过 Smad3 与 miR-195 启动子结合,并导致与 miR-195 启动子相关的组蛋白低乙酰化在肝癌细胞中。这导致 miR-195 的转录抑制,随后破坏 TGF-β-miR-195 调节环并逃避 TGF-β 介导的生长抑制。此外,在肝癌细胞中沉默 HDAC1 恢复了 TGF-β 介导的生长抑制,但如果 miR-195 表达降低,这种作用会减弱。这些发现表明,HDAC1 诱导的 miR-195 下调是肿瘤细胞抵抗 TGF-β 细胞增殖活性的重要机制,并强调了 TGF-β-Smad2/3-miR-195-Smad7 回路在防止不受控制的细胞增殖中的重要性。